Historically, patient-reported outcome measures were primarily utilized for research purposes in orthopedics.However, renewed ...

ECOG performance status was found to capture only part of the patient experience in gastric/GEJ adenocarcinoma. Among patients with gastric or gastroesophageal junction (GEJ) adenocarcinoma, those ...

Measuring treatment success in Sjögren's disease requires more than tracking systemic disease activity alone. Fatigue, pain, dryness, and daily function often drive patients' quality of life and may ...

Improved QOL is observed in patients over two years post-infusion and those without disease progression, highlighting the ...

To say “no” would be to ignore the fact that we have been collecting patient-reported outcome measures for more than 10 years. This effort began in orthopedics as a small pilot project at my ...

Major hospital rankings will be released throughout 2026, giving Long Island patients fresh data on safety, patient outcomes ...

A recent study reveals comparable outcomes for radical cystectomy and bladder-sparing therapy in treating recurrent high-grade bladder cancer, emphasizing patient-centered care.

Pooled trial data show gepotidacin provides early, meaningful symptom relief comparable to nitrofurantoin in uncomplicated ...

Ablation of the posterior nasal nerve using the NEUROMARK system led to greater reductions in nasal symptoms and improvements ...

About 20% of U.S. adults experience major depression in their lifetime. For most people, symptoms improve within a few ...

Invitation-only working summit convenes FDA, CMS, and industry leaders April 10 in Charlotte, North Carolina. This call ...

Researchers found race-, sex-, and age-based disparities in JIA outcomes, with Black children showing worse pain and disease activity than their White peers.